* Based on a 2023 survey by Cerner Enviza of 500 doctors who recommend weight loss programs to patients.
A., Raynor, H
For most people trying to access GLP-1 medications for weight loss, the practical choice is compounded medication through a telehealth provider at $147280/month, not brand-name through insurance
This includes people with chronic kidney failure, Noon and Syndrome, Turner Syndrome, Prader-Willi Syndrome, short stature at birth with no Catch-Up growth, and other causes
Endogenous oxalate synthesis, a major risk factor for calcium oxalate kidney stones, may be increased in MASLD via decline in the activity of enzymes involved in the detoxification of glyoxylate, the immediate precursor of oxalate
doi: 10.4049/jimmunol.170.4.1635